Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study

Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study

Abstract Background Inhaled corticosteroids (ICS) are indicated for prevention of exacerbations in patients with COPD, but they are frequently overprescribed. ICS withdrawal has been recommended by international guidelines in order to prevent side effects in patients in whom ICS are not indicated. M...

Full description

Bibliographic Details
Main Authors: Helgo Magnussen, Sarah Lucas, Therese Lapperre, Jennifer K. Quint, Ronald J. Dandurand, Nicolas Roche, Alberto Papi, David Price, Marc Miravitlles, the Respiratory Effectiveness Group (REG)
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Respiratory Research
Subjects:
COPD
Inhaled corticosteroids
Withdrawal
Real life
Effectiveness
Online Access:https://doi.org/10.1186/s12931-021-01615-0

Internet

https://doi.org/10.1186/s12931-021-01615-0

Similar Items